Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Assets Average (2020 - 2025)

Biodesix's Assets Average history spans 6 years, with the latest figure at $88.1 million for Q4 2025.

  • For Q4 2025, Assets Average fell 11.9% year-over-year to $88.1 million; the TTM value through Dec 2025 reached $88.1 million, down 11.9%, while the annual FY2025 figure was $92.4 million, 5.92% down from the prior year.
  • Assets Average reached $88.1 million in Q4 2025 per BDSX's latest filing, roughly flat from $88.2 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $118.3 million in Q1 2021 to a low of $68.4 million in Q2 2022.
  • Average Assets Average over 5 years is $89.5 million, with a median of $88.2 million recorded in 2025.
  • Peak YoY movement for Assets Average: crashed 41.77% in 2022, then soared 32.95% in 2024.
  • A 5-year view of Assets Average shows it stood at $83.0 million in 2021, then decreased by 6.01% to $78.1 million in 2022, then increased by 19.08% to $92.9 million in 2023, then rose by 7.59% to $100.0 million in 2024, then fell by 11.9% to $88.1 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Assets Average are $88.1 million (Q4 2025), $88.2 million (Q3 2025), and $87.0 million (Q2 2025).